Ozempic and Wegovy: Scientists Uncover New Risks of Popular Weight-Loss “Miracle Drugs” SciTechDailyMapping the effectiveness and risks of GLP-1 receptor agonists Nature.comWeight-loss jabs linked to reduced risk of 42 conditions including dementia The GuardianDo GLP-1 drugs have health risks beyond their weight loss benefits? Medical News TodayGLP-1s: Good News, Bad News Medscape